Poster Session D - Tuesday Morning
Category: Interventional Endoscopy
Terry Jue, MD
Mayo Clinic Arizona
Scottsdale, AZ
Symptom Score Measuring MCID Response | Associated with Improved Response | Associated with Poorer Response | ||
Factor | P Value | Factor | P Value | |
Overall GCSI score | Higher basal individual postprandial fullness score | 0.04 | Higher number of botulinum toxin injections | 0.08 |
Prior metoclopramide use | 0.08 | |||
Nausea/vomiting GCSI subscore | Higher basal NV GCSI subscore | 0.03 | Diabetic gastroparesis etiology | 0.09 |
Higher basal individual nausea score | 0.02 | Fibromyalgia | 0.09 | |
Higher basal individual vomiting score | 0.03 | |||
Early satiety/fullness GCSI subscore | Higher basal NV GCSI subscore | 0.03 | Fibromyalgia | 0.06 |
Higher basal ES GCSI subscore | 0.01 | |||
Higher basal individual postprandial fullness score | 0.001 | Prior opioid use | 0.06 | |
Prior metoclopramide use | 0.01 | |||
Bloating/distention GCSI subscore | IBS | 0.04 |